Signaling Pathways - CREBBP - Insulin-like growth factors (IGFs) - DOT1L - KDR
清除全部
- B3709 Midostaurin (PKC412)中文名: 米哚妥林Target: PKC|PKA|KDR|Flk1|PPK|c-Syk|CDK1/CyclinBSummary: PKC抑制剂
- B1581 EPZ004777 HClTarget: DOT1LSummary: DOT1L抑制剂
- B1404 DCC-2036 (Rebastinib)Target: FLT3|Bcr-Abl|Tie-2|KDRSummary: Bcr-Abl抑制剂
- A8620 AZD-34633 CitationTarget: ALK|Insulin-like growth factors (IGFs)Summary: ALK/IGF1R抑制剂
- A4491 SGC-CBP302 CitationTarget: CREBBP|EP300Summary: CREBBP/EP300 bromodomain抑制剂
- A4490 I-CBP 112Target: CREBBP|EP300Summary: CBP/EP300 bromodomain抑制剂
- A4170 EPZ004777Target: DOT1LSummary: DOT1L抑制剂
- A4166 EPZ56761 CitationTarget: DOT1LSummary: DOT1L抑制剂